2,670
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Metabolite profiling of ascidian Styela plicata using LC–MS with multivariate statistical analysis and their antitumor activity

ORCID Icon, , ORCID Icon, & ORCID Icon
Pages 614-623 | Received 24 Nov 2016, Accepted 25 Nov 2016, Published online: 24 Feb 2017

References

  • Davidson BS. Ascidians: producers of amino acid-derived metabolites. Chem Rev 1993;93:1771–91.
  • Yamaguchi K, Konosu S. Extractive nitrogenous constituents of two species of edible ascidians Styela clava and S. plicata. Nippon Suisan Gakkaishi 1991;57:169–74.
  • Oh KS, Kim JS, Heu MS. Food constituents of edible ascidians Halocynthia roretzi and Pyura michaelseni. Korean J Food Sci Tech 1997;29:955–62.
  • Kuhlisch C, Pohnert G. Metabolomics in chemical ecology. Nat Prod Rep 2015;32:937–55.
  • Powers R. NMR metabolomics and drug discovery. Magn Reson Chem 2009;47:S2–11.
  • Goulitquer S, Potin P, Tonon T. Mass spectrometry-based metabolomics to elucidate functions in marine organisms and ecosystems. Mar Drugs 2012;10:849–80.
  • Lang G, Mayhudin NA, Mitova MI, et al. Evolving trends in the dereplication of natural product extracts: new methodology for rapid, small-scale investigation of natural product extracts. J Nat Products 2008;71:1595–9.
  • Neumann S, Böcker S. Computational mass spectrometry for metabolomics: identification of metabolites and small molecules. Anal Bioanal Chem 2010;398:2779–88.
  • Ferlay JE, Steliarova-Foucher J, Lortet-Tieulent Sonia Rosso JWW, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013;49:1374–403.
  • Halouska S, Fenton RJ, Barletta RG, Powers R. Predicting the in vivo mechanism of action for drug leads using NMR metabolomics. ACS Chem Biol 2011;7:166–71.
  • Molinski TF, Doralyn S, Dalisay Sarah L, et al. Drug development from marine natural products. Nat Rev Drug Discov 2009;8:69–85.
  • Kott P. Tunicata. Zoo Cata Australia 1998;34:51–252.
  • Griffiths P, de Hasseth JA, Fourier Transform Infrared Spectrometry (2nd ed.). New York: Wiley-Interscience; 2007.
  • Smith CA, O'Maille G, Want EJ, et al. METLIN: a metabolite mass spectral database. Ther Drug Monit 2005;27:747–51.
  • Mahieu NG, Genenbacher JL, Patti GJ. A roadmap for the XCMS family of software solutions in metabolomics. Curr Opin Chem Biol 2016;30:87–93.
  • Tran TD, Pham NB, Ekins M, et al. Isolation and total synthesis of stolonines A–C, unique taurine amides from the Australian marine tunicate Cnemidocarpa stolonifera. Mar Drugs 2015;13:4556–75.
  • Di Martile M, Desideri M, De Luca T, et al. Histone acetyl transferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells. Oncotarget 2016;7:11332–48.
  • Sidebottom AM, Johnson AR, Karty JA, et al. Integrated metabolomics approach facilitates discovery of an unpredicted natural product suite from Streptomyces coelicolor M145. ACS Chem Bio 2013;8:2009–16.
  • Sirirak T, Kittiwisut S, Janma C, et al. Kabiramides J and K, trisoxazole macrolides from the sponge Pachastrissa nux. J Nat Prod 2011;74:1288–92.
  • Anzenbacher P, Zanger UM, (Eds.), Metabolism of drugs and other xenobiotics. Weinheim, Germany: Wiley-VCH; 2012.
  • Lacey CS. Interaction of dicloxacillin with warfarin. Ann Pharmacother 2004;38:898.
  • Stoecker D. Relationship between chemical defense and ecology of benthic ascidians. Mar Eco Prog Ser 1980;3:257–65.
  • Pohnert G. Diatom/copepod interactions in plankton: the indirect chemical defense of unicellular algae. ChemBioChem 2005;6:946–59.
  • Müller-Navarra DC, Brett MT, Liston AM, Goldman CR. A highly unsaturated fatty acid predicts carbon transfer between primary producers and consumers. Nature 2000;403:74–7.
  • Roje-Busatto R, Ujević I. PSP toxins profile in ascidian Microcosmus vulgaris (Heller, 1877) after human poisoning in Croatia (Adriatic Sea). Toxicon 2014;79:28–36.
  • Marshall JA, Nichols PD, Hallegraeff GM. Chemotaxonomic survey of sterols and fatty acids in six marine raphidophyte algae. J Appl Phycol 2002;14:255–65.
  • Farag MA, Porzel A, Al-Hammady MA, et al. Soft corals biodiversity in the Egyptian Red Sea: a comparative MS and NMR metabolomics approach of wild and aquarium grown species. J Proteome Res 2016;15:1274–87.
  • Tincu JA, Menzel LP, Azimov R, et al. Plicatamide, an antimicrobial octapeptide from Styela plicata hemocytes. J Biol Chem 2003;278:13546–53.
  • Wasylyk JM, Alam M. Isolation and identification of a new cembranoidditerpene from the tunicate Styelaplicata. J Nat Pro 1989;52:1360–2.
  • Belmiro CL, Castelo-Branco MT, Melim LM, et al. Unfractionated heparin and new heparin analogues from ascidians (chordate-tunicate) ameliorate colitis in rats. J Biol Chem 2009;284:11267–78.
  • Ping SU, Yan XU, Jialin Y, Chang-Yun W. Study on the chemical constituents and bioactivity of the ascidian Styelaplicata, China. Chin J Mar Drug 2014;33:1–6.
  • Jimenez PC, Fortier SC, Lotufo TM, et al. Biological activity in extracts of ascidians (Tunicata, Ascidiacea) from the northeastern Brazilian coast. J Exp Mar Boil Ecol 2003;287:93–101.
  • Satheesh Kumar P, Morabito R, Remigante A, et al. Biological activity of extract from Styela plicata and Ascidia mentula (Ascidiacea). J Biol Res 2016;89:5812–18.
  • Nurhayati APD, Pratiwi R, Wahyuono S, Fadlan A. Isolation and identification of alkaloid compound of marine sponge Cinachyrella sp. (Family Tetillidae). J Adv Botany Zool 2014;2:1–4.
  • Aiello A, Fattorusso E, Menna M, et al. Novel anti-proliferative alkylsulfates from the Mediterranean tunicate Ascidia mentula. Tetrahedron 1997;53:5877–82.
  • Jimenez PC, Wilke DV, Takeara R, Lotufo TM, et al. Cytotoxic activity of a dichloromethane extract and fractions obtained from Eudistoma vannamei (Tunicata: Ascidiacea). Comp Biochem Physiol A Mol Integr Physiol 2008;151:391–8.
  • Takeara R, Jimenez PC, Wilke DV, et al. Antileukemic effects of Didemnum psammatodes (Tunicata: Ascidiacea) constituents. Comp Biochem Physiol A Mol Integr Physiol 2008;151:363–9.
  • Crunkhorn S. Breast cancer: inhibiting fatty acid oxidation blocks tumour growth. Nat Rev Drug Discov 2016;15:310.
  • Hardy S, El-Assad W, Przybytkowski E, et al. Saturated fatty acid-induced apoptosis in MDA-MB-231 breast cancer cells. A role for cardiolipin. J Biol Chem 2003;278:31861–70.
  • Faivre S, Chièze S, Delbaldo C, et al. Phase I and pharmacokinetic study of aplidine, a new marine cyclodepsipeptide in patients with advanced malignancies. J Clin Oncol 2005;23:7871–80.
  • Russo GL, Ciarcia G, Presidente E, et al. Cytotoxic and apoptogenic activity of a methanolic extract from the marine invertebrate Ciona intestinalis on malignant cell lines. Med Chem 2008;4:106–9.
  • Rajesh RP, Ramasamy SM, Murugan A. Anticancer activity of the ascidian Polyclinum indicum against cervical cancer cells (HeLa) mediated through apoptosis induction. Med Chem 2010;6:396–405.
  • Takebayashi Y, Goldwasser F, Urasaki Y, et al. Ecteinascidin 743 induces protein-linked DNA breaks in human colon carcinoma HCT116 cells and is cytotoxic independently of topoisomerase I expression. Clin Cancer Res 2001;7:185–91.
  • Sakai R, Kishore V, Kundu B, et al. Structure-activity relationships of the didemnins. J Med Chem 1996;39:2819–34.
  • Erba E, Serafini M, Gaipa G, et al. Effect of aplidin in acute lymphoblastic leukaemia cells. Br J Cancer 2003;89:763–73.
  • Ko-Hsiu L, Ko-Huang L, Hsien-Hua L, et al. Induction of caspase-3-dependent apoptosis in human leukemia HL-60 cells by paclitaxel. Clin Chim Acta 2005;357:65–73.
  • Gompel M, Leost M, Joffe EBD, et al. Meridianins, a new family of protein kinase inhibitors isolated from the ascidian Aplidium meridianum. Bioorg Med Chem Lett 2004;14:1703–7.
  • Richardson AD, Ireland CA. A profile of the in vitro antitumor activity of lissoclinolide. Toxicol Appl Pharmacol 2004;195:55–61.